SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.19m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Licence agreement with Proton Technologies Canada

1 Feb 2022 14:43

RNS Number : 3626A
Sabien Technology Group PLC
01 February 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

1 February 2022

 

Sabien Technology Group plc

("Sabien" or the "Company" or the "Licensee")

 

Update on Licence agreement with Proton Technologies Canada Inc.

The Board of Sabien Technology Group plc (AIM:SNT), a Company focused on a Green Aggregation Strategy, announces today that it has signed a Licence Agreement (the "Agreement") with Proton Technologies Canada Inc., ("Proton" or the "Licensor") in relation to a hydrogen processing licence within UK territories and an option over the construction and operation of a City Oil Field ("COF") facility located on Proton's site in Saskatchewan, Canada. This follows on from the signed Heads of Terms announced on 11 November 2021.

The key elements of the Agreement are:

1. Proton grants to Sabien a non-transferable, non-exclusive license to use and exploit any and all of Proton's Technology Rights, for producing up to 20 tonnes of hydrogen per day in total, within the onshore areas of the United Kingdom (Great Britain and Northern Ireland) and the offshore areas within United Kingdom Territorial Waters for the purpose of making hydrogen and sequestering carbon using the processes provided for within the Proton's patents and intellectual property (the "License"). The Licence is non-transferable except to majority owned or controlled subsidiaries of the Licensee or in all other cases by written unanimous consent of the directors of the Licensor. Quantities of hydrogen to be recorded by Sabien and reported to Proton on a monthly basis.

2. Proton hereby grants an option to install an initial 24 tonnes per day, and up to 120 tonnes/day COF recycling plant (the "Facility") on the Licensor's site in Saskatchewan, Canada (the "Site"), the Facility is to be developed and operated through a special purpose vehicle, in which it is anticipated that Sabien will hold a minority equity position (the "SPV"), the SPV is to be externally funded. The parties acknowledge and agree that:

· installation of the Facility at the Site is subject to regulatory approval (environmental and planning), which will be applied for when commercially expedient;

· subject to receiving such approvals, the parties shall enter into an agreement (the "Facility License"). Subject to contract, the parties have agreed in principle that, under the terms of the Facility License, the SPV will pay to Proton a royalty on the same basis as the hydrogen royalty set out in the Agreement, based on the oil produced or consumed by the Facility;

· Sabien may appoint third party contractors to install the Facility at the Site on terms to be agreed between Sabien, Proton, and such third party; and

· the rights granted to the Sabien are at the option of the Licensee. In the event that the Approvals are not granted (or are subject to conditions not commercially viable to Sabien) then Sabien is not obliged to install the Facility at the Site.

 

3. Proton to provide all necessary technical assistance to validate suitable sites and to provide advice on establishing and operating the installation.

 

4. Consideration of £100,000 in cash. The royalty payable to Proton is US$0.05 per kg or H2 extracted and 2% of the value of any CO2 derived, offsetable against the cash consideration already paid, with minimum royalty payments of US$25,000 per annum from year 5; and

 

5. 280,000 warrants to be issued with exercise price of 60 pence per ordinary share of 3 pence each with an expiry date of 19 February 2023. The quantum of warrants was agreed as if the £100,000 cash consideration was paid in shares on a 1:1 basis at a share price of 35.7p.

 

Commenting on the Proton licence deal, Richard Parris, Executive Chairman, said:

"Sabien is delivering on its strategy of building a portfolio of operations which, in combination, provide critical elements of the transition to a Green Economy. Following Sabien's initial investment in Proton announced 14 October 2021, the Board is pleased to have now concluded this significant licence deal with Proton. This Agreement provides Sabien with an entry into the UK hydrogen market, secures a North American commercial entry for Sabien and helps to cement our relationship with City Oil Field of Korea".

Further Information:

Sabien Technology Group plc

Richard Parris, Executive Chairman

 

+44 20 7993 3700

 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss

 

+44 203 328 5656

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams

+44 207 469 0930

 

The person who arranged for the release of this announcement on behalf of the Company was Richard Parris, Executive Chairman.

A copy of this announcement will be available from the Company's website at www.sabien-tech.com

Further information on Proton Technologies Canada Inc., can be viewed at Lowest cost Hydrogen with Zero Emissions. (proton.energy)

A copy of the JS Global Advisory report is available on the Company's website at  https://sabien.com/wp-content/uploads/2021/11/Clear-Hydrogen-in-UK-.pdf

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRBSGDDGSGDGDB
Date   Source Headline
11th Jun 20267:00 amRNSIssue of shares to directors & broker
2nd Jun 20267:00 amRNSProposed balance sheet strengthening & M2G update
29th May 20265:00 pmRNSTotal Voting Rights
21st May 20267:00 amRNSProposed Commercial Partnership & Investment
20th May 20266:22 pmRNSSettlement of Historical Contract
31st Mar 20267:00 amRNSHalf-year Report for the 6 months to 31 Dec 2025
10th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Jan 20265:30 pmRNSHolding(s) in Company
22nd Dec 202512:02 pmRNSUpdate on Funding and Strategic Arrangements
22nd Dec 202512:02 pmRNSUpdate on Funding and Strategic Arrangements
9th Dec 20251:20 pmRNSResult of Annual General Meeting
9th Dec 20257:00 amRNSAGM Statement & Trading Update
19th Nov 20257:00 amRNSProposed Strategic Agreement with COF
13th Nov 20257:00 amRNSFinal Results for the Year Ended 30 June 2025
10th Nov 20257:00 amRNSNew Factoring Facility
5th Nov 202512:01 pmRNSAppointment of Corporate Broker
2nd Oct 202512:06 pmRNSFurther update on Sabien, b.grn & related matters
19th Sep 20257:00 amRNSTrading Update
31st Jul 20254:59 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSYear End Trading Update
30th Jun 20252:53 pmRNSIssue of shares to directors
23rd Jun 20254:28 pmRNSHolding(s) in Company
17th Mar 20257:00 amRNSHalf-year Report for the 6 months to 31 Dec 2024
6th Feb 202511:43 amRNSUpdate in relation to Aeristech Limited
27th Jan 20257:00 amRNSTrading update - acceleration of new M2G orders
31st Dec 202412:30 pmRNSTotal Voting Rights
19th Dec 202410:51 amRNSResult of Annual General Meeting
19th Dec 20247:00 amRNSUpdate on US Waste Plastics to Oil Project
28th Nov 20247:00 amRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSIssue of shares to non-executive directors
18th Nov 20247:00 amRNSFinal Results & Annual Report & Accounts for 2024
11th Nov 20247:00 amRNSNew M2G Cloud Connection System Order
17th Oct 20247:00 amRNSUpdate on US Waste Plastics to Oil Project
30th Sep 20245:00 pmRNSTotal Voting Rights
26th Sep 20244:21 pmRNSDirector/PDMR Shareholding
19th Sep 20241:00 pmRNSHolding(s) in Company
4th Sep 20245:30 pmRNSAdmission of New Shares & Total Voting Rights
29th Aug 20244:00 pmRNSUpdate on Admission of New Ordinary Shares
20th Aug 20247:00 amRNSRelated Party Funding
8th Jul 20248:15 amRNSTrading Statement
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 202411:52 amRNSHolding(s) in Company
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 202411:27 amRNSResult of Broker Option, Issue of Equity and TVR
20th Feb 20243:45 pmRNSDirector/PDMR Shareholding
19th Feb 20247:45 amRNSPlacement and Broker Option
19th Feb 20247:30 amRNSHalf-year Report for the 6 months to 31 Dec 2023
7th Feb 20247:00 amRNSNew system installed at Hampton Court Palace

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.